| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2025 |
| Sales | 80 | 210 | 330 | 530 | 0 |
| Sales Growth | -61.90% | -36.36% | -37.74% | unch | unch |
| Net Income | -4,090 | -3,700 | -1,050 | -2,470 | 0 |
| Net Income Growth | -10.54% | -252.38% | +57.49% | unch | unch |
Seqll Inc (SQL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
SeqLL Inc. is a development-stage life sciences instrumentation and research services company. It engaged in the development of scientific assets and novel intellectual property across multiple omics fields. SeqLL Inc. is based in WOBURN, MA.